ABBV vs WFC: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Wells Fargo & Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-17.
AbbVie Inc. · Healthcare
$261.07
+1.2% upside to fair value
Grade C
High Quality
VS
Wells Fargo & Company · Financial Services
$87.53
+18.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
WFC has more upside to fair value
(+18.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
WFC |
| Current Price |
$261.07 |
$87.53 |
| Fair Value Estimate |
$264.30 |
$103.38 |
| Upside to Fair Value |
+1.2%
|
+18.1%
|
| Market Cap |
$461.3B |
$267.8B |
| Forward P/E |
128.0x
|
—
|
| EV / EBITDA |
31.0x
|
15.8x
|
| Price / Sales |
7.3x
|
2.1x
|
| Price / FCF |
22.1x
|
226.4x
|
| Revenue Growth YoY |
+12.4%
|
+11.3%
|
| Gross Margin |
70.7%
|
64.5%
|
| Operating Margin |
27.6%
|
21.2%
|
| Return on Equity |
68.0%
|
12.6%
|
| Dividend Yield |
0% |
2.06% |
| FCF Yield |
4.52%
|
0.44%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology and aesthetics. The company is transitioning from its historical Humira dominance, which has faced loss of exclusivity, toward high-growth assets like Skyrizi and Rinvoq that are driving robust revenue growth of 12.4% in the most recent quarter. Despite strong revenue growth and a dura…
Wells Fargo is a diversified U.S. bank operating consumer and commercial banking, corporate and investment banking, and wealth management, supported by a large deposit franchise, a $2.3 trillion asset base, nationwide advisory distribution, and increasingly relevant capital-markets capabilities. Business quality is high but not without legacy constraints: return on equity is 12.6%, gross margin i…
Accumulation Zones
| Metric |
ABBV |
WFC |
| Zone Low |
$198.23 |
$77.53 |
| Zone High |
$224.66 |
$87.87 |
| In Buy Zone? |
No
|
Yes
|